About Specific Targets and Collateral Damage.

[1]  Sanghamitra Mohanty,et al.  Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients: Results From the Randomized OASIS Trial. , 2016, Journal of the American College of Cardiology.

[2]  Sanghamitra Mohanty,et al.  Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. , 2016, Heart rhythm.

[3]  Gerhard Hindricks,et al.  Successful Repeat Catheter Ablation of Recurrent Longstanding Persistent Atrial Fibrillation With Rotor Elimination as the Procedural Endpoint: A Case Series , 2016, Journal of cardiovascular electrophysiology.

[4]  P. Sanders,et al.  A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study). , 2015, European heart journal.

[5]  Nazem Akoum,et al.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.

[6]  R. Figlin,et al.  Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib , 2011, Journal of the National Cancer Institute.

[7]  Paul J. Wang,et al.  Left Atrial Appendage: An Underrecognized Trigger Site of Atrial Fibrillation , 2010, Circulation.

[8]  B. Knight,et al.  Approaches to catheter ablation of persistent atrial fibrillation. , 2009, Heart rhythm.

[9]  S. Themistoclakis,et al.  Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. , 2016, Heart rhythm.